Picture of Ajanta Pharma logo

AJANTPHARM — Ajanta Pharma News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Brief: Ajanta Pharma gets USFDA nod for Duloxetine Hydrochloride delayed release capsules

Jan 9 (Reuters) - Ajanta Pharma Ltd  AJPH.NS : 
    * Says Ajanta Pharma announces US FDA approval for 
Duloxetine Hydrochloride delayed release capsules 
    * Says company will be launching the product shortly in 3 
strengths, 20 mg, 30 mg and 60 mg strengths capsules 
 
Source text: http://bit.ly/2i9tdsI 
Further company coverage:  AJPH.NS  
 
 ((Bangalore.newsroom@thomsonreuters.com;))

Recent news on Ajanta Pharma

See all news